首页> 外文期刊>老年心脏病学杂志(英文版) >Twenty-four-hour ambulatory blood pressure changes in older patients with essential hypertension receiving monotherapy or dual combination antihypertensive drug therapy
【24h】

Twenty-four-hour ambulatory blood pressure changes in older patients with essential hypertension receiving monotherapy or dual combination antihypertensive drug therapy

机译:老年原发性高血压患者接受单一疗法或双重降压药物疗法的24小时动态血压变化

获取原文
获取原文并翻译 | 示例
       

摘要

Objective To evaluate the differences in 24-hour ambulatory blood pressure (BP) in older patients with hypertension treated with the five major classes of antihypertensive drugs,as monotherapy or dual combination therapy,to improve daytime and nighttime BP control.Methods We enrolled 1920 Chinese community-dwelling outpatients aged ≥ 60 years and compared ambulatory BP values and ambulatory BP control (24-hour BP < 130/80 mmHg;daytime mean BP < 135/85 mmHg;and nighttime mean BP < 120/70 mmHg),as well as nighttime BP dip patterns for monotherapy and dual combination therapy groups.Results Patients' mean age was 71 years,and 59.5% of patients were women.Calcium channel blockers (CCBs) constituted the most common (60.3% of patients) monotherapy,and renin-angiotensin system (RAS) blockers combined with CCBs was the most common (56.5% of patients) dual combination therapy.Monotherapy with beta-blockers (BB) provided the best daytime BP control.The probabilities of having a nighttime dip pattern and nighttime BP control were higher in patients receiving diuretics compared with CCBs (OR =0.52,P =0.05 and OR =0.41,P =0.007,respectively).Patients receiving RAS/diuretic combination therapy had a higher probability of having controlled nighttime BP compared with those receiving RAS/CCB (OR =0.45,P =0.004).Compared with RAS/diuretic therapy,BB/CCB therapy had a higher probability of achieving daytime BP control (OR =1.27,P =0.45).Conclusions Antihypertensive monotherapy and dual combination drug therapy provided different ambulatory BP control and nighttime BP dip patterns.BB-based regimens provided lower daytime BP,whereas diuretic-based therapies provided lower nighttime BP,compared with other antihypertensive regimens.
机译:目的探讨五种主要降压药物(单一疗法或双重联合疗法)治疗的老年高血压患者24小时动态血压的差异,以改善白天和晚上的血压控制。方法我们纳入了1920名中国人。以及≥60岁的社区居住门诊患者,并比较了动态血压值和动态血压控制(24小时血压<130/80 mmHg;日平均血压<135/85 mmHg;夜间平均BP <120/70 mmHg),以及结果患者的平均年龄为71岁,女性为59.5%,女性中钙通道阻滞剂(CCBs)最为常见(占患者的60.3%),肾素血管紧张素系统(RAS)受体阻滞剂与CCB联合使用最为常见(占患者的56.5%)。单用β受体阻滞剂(BB)的单药治疗可以最好地控制白天的血压。与CCB相比,接受利尿剂的患者的夜间和夜间BP控制更高(分别为OR = 0.52,P = 0.05和OR = 0.41,P = 0.007)。接受RAS /利尿剂联合治疗的患者夜间BP控制的可能性更高与接受RAS / CCB的患者相比(OR = 0.45,P = 0.004)。与RAS /利尿剂治疗相比,BB / CCB治疗具有实现白天BP控制的可能性更高(OR = 1.27,P = 0.45)。与其他降压方案相比,以BB为基础的治疗方案可降低白天的BP,而以利尿剂为基础的治疗方案可以降低夜间的BP。

著录项

  • 来源
    《老年心脏病学杂志(英文版)》 |2019年第4期|354-361|共8页
  • 作者单位

    Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China;

    Clinical Trial and Research Center, Beijing Hypertension League Institute, Chinese Hypertension League, Beijing, China;

    Department of Traditional Chinese Medicine, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China;

    Clinical Trial and Research Center, Beijing Hypertension League Institute, Chinese Hypertension League, Beijing, China;

    Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China;

    Department of Traditional Chinese Medicine, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China;

    Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China;

    Clinical Trial and Research Center, Beijing Hypertension League Institute, Chinese Hypertension League, Beijing, China;

    Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China;

    Clinical Trial and Research Center, Beijing Hypertension League Institute, Chinese Hypertension League, Beijing, China;

    Clinical Trial and Research Center, Beijing Hypertension League Institute, Chinese Hypertension League, Beijing, China;

    Clinical Trial and Research Center, Beijing Hypertension League Institute, Chinese Hypertension League, Beijing, China;

    Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China;

    Clinical Trial and Research Center, Beijing Hypertension League Institute, Chinese Hypertension League, Beijing, China;

    Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China;

    Clinical Trial and Research Center, Beijing Hypertension League Institute, Chinese Hypertension League, Beijing, China;

    Xinjiekou Community Health Service Center, Beijing, China;

    Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China;

  • 收录信息 中国科学引文数据库(CSCD);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-19 04:25:44
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号